- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-4)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 4 residues within 4Å:- Chain A: N.106, H.123, D.271
- Chain M: R.90
No protein-ligand interaction detected (PLIP)NAG-NAG.5: 4 residues within 4Å:- Chain B: N.106, L.125, D.271
- Chain N: R.90
No protein-ligand interaction detected (PLIP)NAG-NAG.9: 5 residues within 4Å:- Chain C: N.106, H.123, L.125, D.271
- Chain O: R.90
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.3: 8 residues within 4Å:- Chain A: E.162, K.203, N.213, C.328, G.329, C.382, V.383
- Ligands: NAG.11
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:E.162
- Hydrogen bonds: A:G.329
NAG-NAG-BMA.6: 8 residues within 4Å:- Chain B: E.162, K.203, N.213, C.328, G.329, V.383, S.384
- Ligands: NAG.21
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:E.162
- Hydrogen bonds: B:E.162, B:E.162, B:G.329
NAG-NAG-BMA.7: 10 residues within 4Å:- Chain C: E.162, P.163, K.203, N.213, C.328, G.329, C.382, V.383, S.384
- Ligands: NAG.42
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:E.162
- Hydrogen bonds: C:G.329
- 33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG.10: 2 residues within 4Å:- Chain A: N.51
- Chain D: S.10
Ligand excluded by PLIPNAG.11: 6 residues within 4Å:- Chain A: N.213, L.216, P.242, V.383, N.385
- Ligands: NAG-NAG-BMA.3
Ligand excluded by PLIPNAG.12: 2 residues within 4Å:- Chain A: N.96, Q.138
Ligand excluded by PLIPNAG.13: 6 residues within 4Å:- Chain A: T.187, E.226, N.227
- Chain P: Y.31, N.32, Y.33
Ligand excluded by PLIPNAG.14: 4 residues within 4Å:- Chain A: N.252, T.254, I.273, Q.377
Ligand excluded by PLIPNAG.15: 1 residues within 4Å:- Chain A: N.342
Ligand excluded by PLIPNAG.16: 3 residues within 4Å:- Chain A: N.313, S.314, S.315
Ligand excluded by PLIPNAG.17: 3 residues within 4Å:- Chain A: N.185, T.187, S.225
Ligand excluded by PLIPNAG.18: 4 residues within 4Å:- Chain A: Q.244, N.246, S.284, R.381
Ligand excluded by PLIPNAG.19: 4 residues within 4Å:- Chain A: Q.93, N.110, R.119
- Chain C: D.117
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain B: E.50, N.51
- Chain E: S.10
Ligand excluded by PLIPNAG.21: 6 residues within 4Å:- Chain B: N.213, L.216, P.242, V.383, N.385
- Ligands: NAG-NAG-BMA.6
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain B: N.96, I.101
Ligand excluded by PLIPNAG.23: 6 residues within 4Å:- Chain B: T.187, E.226, N.227
- Chain Q: Y.31, N.32, Y.33
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain B: N.252, T.254, Q.377
Ligand excluded by PLIPNAG.25: 1 residues within 4Å:- Chain B: N.342
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain B: N.313, S.314, S.315
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain B: N.185, T.187
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain B: Q.244, N.246
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain B: Q.93, N.110, R.119
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain C: E.50, N.51
- Chain F: S.10
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain C: N.96, K.128, N.139
Ligand excluded by PLIPNAG.32: 4 residues within 4Å:- Chain C: T.187, E.226, N.227
- Ligands: NAG.36
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain C: N.252, T.254, I.273
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain C: N.342
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain C: N.313, S.314, S.315
Ligand excluded by PLIPNAG.36: 6 residues within 4Å:- Chain C: N.185, G.186, T.187, I.223, S.225
- Ligands: NAG.32
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain C: Q.244, N.246, S.284
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain C: Q.93, N.110, R.119
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain D: K.97, N.101
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain E: K.97, N.101
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain F: K.97, E.98, N.101
Ligand excluded by PLIPNAG.42: 4 residues within 4Å:- Chain C: L.216, V.383, N.385
- Ligands: NAG-NAG-BMA.7
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dam, K.A. et al., HIV-1 CD4-binding site germline antibody-Env structures inform vaccine design. Nat Commun (2022)
- Release Date
- 2022-11-09
- Peptides
- Envelope glycoprotein gp120: ABC
Envelope glycoprotein gp41: DEF
10-1074 Fab heavy chain: GHI
BG24 mature Fab heavy chain: JKL
10-1074 Fab light chain: MNO
BG24 mature Fab light chain: PQR - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
MH
NI
OJ
GK
HL
IM
PN
QO
RP
JQ
KR
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-4)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dam, K.A. et al., HIV-1 CD4-binding site germline antibody-Env structures inform vaccine design. Nat Commun (2022)
- Release Date
- 2022-11-09
- Peptides
- Envelope glycoprotein gp120: ABC
Envelope glycoprotein gp41: DEF
10-1074 Fab heavy chain: GHI
BG24 mature Fab heavy chain: JKL
10-1074 Fab light chain: MNO
BG24 mature Fab light chain: PQR - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
MH
NI
OJ
GK
HL
IM
PN
QO
RP
JQ
KR
L